MMTS™ Multi Mini Tablet System proporcionan la flexibilidad de las formas farmacéuticas multiparticuladas
- Dosificación flexible
- cápsulas
- bolsitas
- sprinkles
- Permite una amplia gama de perfiles de liberación personalizados en una sola cápsula
- Administración precisa a dosis más bajas mediante una gama de tamaños de comprimido
- Una amplia gama de perfiles de liberación personalizados en una sola cápsula permite la titulación de una gama más amplia de dosis.
Sistema multiparticulado con polímeros de liberación controlada
- Las membranas funcionales se aplican a comprimidos cilíndricos de 1,0-2,0 mm para controlar los índices de liberación
- Su pequeño tamaño facilita el desarrollo de productos que pueden ofrecer múltiples fármacos o distintos perfiles de liberación en una sola cápsula.
- Alta capacidad de carga de fármacos con la posibilidad de combinar con una formulación de alta densidad para formulaciones de alta resistencia.
Hable con un experto
Dr. Srinivasan Shanmugam
Executive Director, Pharmaceutical Sciences, Business Support, and New Technologies
Dr. Srinivasan Shanmugam is involved in the development and expansion of Adare’s pharmaceutical technology portfolio and supports product development, co-development, and tech transfer opportunities. Dr. Shanmugam has a Ph.D. M.S., and a B.S. in Pharmacy. Dr. Shanmugam has more than 20 years of experience in designing and development of conventional, NDDS/alternate, advanced/modified drug delivery systems, and pharmaceutical platform technologies for oral and other routes of administration. His expertise includes enabling technologies for challenging drugs and developing platform technologies. Additionally, his expertise includes patient-centric solutions focusing on pediatric and geriatric populations to achieve dose convenience, flexibility, and precision. Dr. Shanmugam has published numerous research articles, holds multiple patents, and is a reviewer/editorial member of various prestigious journals. Shanmugam’s recent work focuses on product development solutions for special patient populations like pediatric and geriatric populations.
